On-demand education

Special series on RCC: Beyond first-line treatment strategies for mRCC with Dr. Mari and Dr. Ciccarese

Duration: Approx. 13 minutes

Special series on RCC: First-line treatment strategies for mRCC with Dr. Mari and Dr. Marandino

Duration: Approx. 14 minutes

Role of cytoreductive nephrectomy for mRCC with Assist. Prof. Mari and Prof. Badani

Duration: Approx. 15 minutes

ASCO GU24 special: Prof. Michael Hofman talks about a novel CA IX-targeting peptide

Duration: Approx. 7 minutes

ASCO GU24 special: Prof. Nizar Tannir shares CheckMate 214 results

Duration: Approx. 13 minutes

ASCO GU24 special: Assoc. Prof. Barata discusses the results of KEYNOTE-564 and CheckMate-914

Duration: Approx. 11 minutes

UROONCO RCC take home message for 2023

Duration: Approx. 18 minutes

Dr. Agarwal shares LITESPARK-013 results: Optimal dose of belzutifan is 120mg

Duration: Approx. 4 minutes

Prof. Roberto Iacovelli: Drug interruptions in mRCC IO-TKI (Avelumab and axitinib) is safe and may reduce toxicity and cost for the treatment

Duration: Approx. 6 minutes

Prof. Albiges shares LITESPARK-005 study results: Belzutifan improves PFS in pretreated mRCC patients

Duration: Approx. 5 minutes

Special series: 3D models for kidney cancer with caval thrombous

Duration: Approx. 12 minutes

Impact of ERAS in Kidney cancer

Duration: Approx. 80 minutes

Special series: Vascular perfusion 3D models and augmented reality for RCC surgery

Duration: Approx. 19 minutes

Discussion with Prof. Badani at ERUS23 on RAPN

Duration: Approx 8 minutes

Prof. Kaouk talks about the novel single-port robotic platform

Duration: Approx. 7min

Surgical complications: An update from Prof. Kutikov on RPN risks

Duration: Approx. 10 minutes